Progesterone for recurrent miscarriage: truth and deceptions

Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 22, Issue 2, 2008, Pages 375-389

  Walch, Katharina T ^a   Huber, Johannes C ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

habitual abortion; immunomodulation; pregnancy loss; progesterone; progestogen; recurrent miscarriage; treatment

Indexed keywords

CHORIONIC GONADOTROPIN; DYDROGESTERONE; FOLIC ACID; HYDROXYPROGESTERONE CAPROATE; MEDROXYPROGESTERONE; MIFEPRISTONE; PLACEBO; PROGESTERONE; VITAMIN;

ANTIBODY PRODUCTION; CELLULAR IMMUNITY; CHROMOSOME ABERRATION; CLINICAL TRIAL; CORPUS LUTEUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MATERNAL STRESS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; TH1 CELL; TH2 CELL; UNSPECIFIED SIDE EFFECT;

ABORTION, HABITUAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; PROGNOSIS;

EID: 39749185425     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.08.009     Document Type: Review

References (100)

1. American College of Obstetricians and Gynecologists (ACOG). Early pregnancy loss. ACOG technical bulletin no. 212 (1995), American College of Obstetricians and Gynecologists, Washington DC
2. Daya S. Evaluation and management of recurrent spontaneous abortion. Curr Opin Obstet Gynecol 8 (1993) 188-192
3. Wilcox A.J., Weinberg C.R., O'Connor J.F., et al. Incidence of early pregnancy loss. N Engl J Med 319 (1988) 189-194
4. Daya S. Immunotherapy for unexplained recurrent spontaneous abortion. Infertil Reprod Med Clin North Am 8 (1997) 65-77
5. Clifford K., Rai R., and Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 12 (1997) 387-389
6. Christiansen O.B., Andersen A.M.N., Bosch E., et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 83 (2005) 821-839
7. Sirrat G.M. Recurrent miscarriage. Lancet 336 (1990) 673-675
8. Manyonda I.T. The immunology of recurrent spontaneous miscarriage. The Immunology of Human Reproduction. 1st edn (2006), Taylor & Francis, London 59-77
9. Vlaanderen W., and Treffers P.K. Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trimester. BMJ 295 (1987) 92-93
10. Tempfer C.B., Kurz C., Bentz E.K., et al. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil Steril 86 (2006) 145-148
11. Roman E.A., Alberman E., and Pharoah P.O. Pregnancy order and fetal loss. BMJ 280 (1980) 715
12. American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin. Management of recurrent early pregnancy loss. Int J Gynecol Obstet 78 (2002) 179-190
13. Stephenson M.D. Management of recurrent early pregnancy loss. J Reprod Med 51 (2006) 303-310
14. Porter T.F., and Scott J.R. Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol 19 (2005) 85-101
15. Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 1 (2003) CD000112
16. Rai R., Backos M., Baxter N., et al. Recurrent miscarriage - an aspirin a day?. Hum Reprod 15 (2000) 2220-2223
17. Arredondo F., and Noble L.S. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 24 (2006) 33-39
18. Di Renzo G.C., Mattei A., Gojnic M., et al. Progesterone and pregnancy. Curr Opin Obstet Gynecol 17 (2005) 589-600
19. Potdar N., and Konje J.C. The endocrinological basis of recurrent miscarriage. Curr Opin Obstet Gynecol 17 (2005) 424-428
20. Csapo A.I., Pilkkinen M.O., and Wiest W.G. Effects of lutectomy and progesterone replacement in early pregnant patients. Am J Obstet Gynecol 115 (1973) 759-764
21. Hensleigh P.A., and Fainstat T. Corpus luteum dysfunction: serum progesterone levels in diagnosis and assessment of therapy for recurrent and threatened abortion. Fertil Steril 32 (1979) 715-719
22. Cumming D.C., Honore L.H., Scott J.Z., et al. The late luteal phase in infertile women: comparison of simultaneous endometrial biopsy and progesterone levels. Fertil Steril 43 (1985) 715-719
23. Insler V. Corpus luteum defects. Curr Opin Obstet Gynecol 4 (1992) 203-211
24. Daya S. Issues in the etiology of recurrent spontaneous abortion. Curr Opin Obstet Gynecol 6 (1994) 153-159
25. Szlachter N., O'Byrne E., Goldsmith L., et al. Myometrial inhibiting activity of relaxin containing extracts of human corpora lutea of pregnancy. Am J Obstet Gynecol 136 (1980) 584-586
26. Dong Y.L., Fang L., Gangula P.R.R., et al. Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biol Reprod 59 (1998) 933-940
27. Simoncini T., Caruso A., Giretti M.S., et al. Effects of dydrogesterone and of its stable metabolite, 20-α-dihydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril 86 Suppl 3 (2006) 1235-1242
28. Goldstein P., Berrier J., Rosen S., et al. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 96 (1989) 265-274
29. Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynaecol 96 (1989) 257-260
30. Oates-Whitehead R.M., Haas D.M., and Carrier J.A.K. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 4 (2003) CD003511
31. El-Zibdeh M.Y. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 97 (2005) 431-434
32. Gruber C.J., and Huber J.C. The role of dydrogesterone in recurrent (habitual) abortion. J Ster Biochem Mol Biol 97 (2005) 426-430
33. Szekeres-Bartho J., Barakonyi A., Par G., et al. Progesterone as an immunomodulatory molecule. Int J Immunopharmacol 1 (2001) 1037-1048
34. Check J.H., Chase J., Nowroozi K., et al. Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters. Int J Fertil 33 (1987) 192-199
35. Giudice L.C. Genes associated with embryonic attachment and implantation and the role of progesterone. J Reprod Med 44 (1999) 165-171
36. Siiteri P.K., Febres F., and Clemens L.E. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann NY Acac Sci 286 (1977) 384-397
37. Wegmann T.G. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr Opin Immunol 2 (1990) 765-769
38. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 47 (2000) 87-103
39. Clark D.A., Coulam C.B., Daya S., et al. Unexplained sporadic and recurrent miscarriage in the new millenium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 7 (2001) 501-511
40. Clark D.A., Arck P.C., and Chaouat G. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at uterine level. Am J Reprod Immunol 41 (1999) 5-22
41. Christiansen O.B. A fresh look at the causes and treatment of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 2 (1996) 271-293
42. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 21 (2002) 471-496
43. Kelemen K., Paldi A., Tinneberg H., et al. Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 39 (1998) 351-355
44. Wegmann T.G., Lin H., Guilbert L., et al. Bidirectional cytokine interactions in maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol Today 14 (1993) 353-356
45. Makhseed M., Raghupathy R., Azizieh F., et al. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 16 (2001) 2219-2226
46. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 18 (1997) 478-482
47. Knackstedt M.K., Zenclussen A.C., Hertwig K., et al. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol 49 (2003) 210-220
48. Clark D.A., Ding J.W., Chaouat G., et al. The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol 42 (1999) 37-42
49. Ragusa A., de Carolis C., dal Lago A., et al. Progesterone supplement in pregnancy: an immunologic therapy?. Lupus 13 (2004) 639-642
50. Kwak-Kim J.Y., Chung-Bang H.S., Ng S.C., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 18 (2003) 767-773
51. Raghupathy R., Makhseed M., Azizieh F., et al. Cytokine production by maternal lymphoctes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15 (2000) 713-718
52. Saito S., and Sakai M. Th1/Th2 balance in preeclampsia. Reprod Immunol 59 (2003) 161-173
53. Makhseed M., Raghupathy R., El-Shazly F., et al. Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 49 (2003) 308-318
54. Carp H. Cytokines in recurrent miscarriage. Lupus 13 (2004) 630-634
55. Chao K.H., Yang Y.S., Ho H.N., et al. Decidual natural killer cytotoxity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am J Reprod Immunol 34 (1995) 274-280
56. Ntrivalas E.I., Kwak-Kim J.Y.H., Gilman-Sachs A., et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 16 (2001) 855-861
57. Aoki K., Kajiura S., Matsumoto Y., et al. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 345 (1995) 1340-1342
58. Ledee-Bataille N., Dubanchet S., Coulomb-L'hermine A., et al. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failures after in vitro fertilization. Fertil Steril 81 (2004) 59-65
59. Clifford K., Flanagan A.M., and Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 14 (1999) 2727-2730
60. Quack K.C., Vassiliadou N., Pudney J., et al. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod 16 (2001) 949-955
61. King A., Jokhi P.P., Burrows T.D., et al. Functions of human decidual NK cells. Am J Reprod Immunol 35 (1996) 258-260
62. Yui J., Garcia-Lloret M., Wegmann T.G., et al. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblast. Placenta 15 (1994) 819-835
63. Malan Borel I., Gentile T., Angelucci J., et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol 20 (1991) 129-140
64. Eblen A.C., Gercel-Taylor C., Shields L.B.E., et al. Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil Steril 73 (2000) 305-313
65. Szekeres-Bartho J., Weill B.J., Mike G., et al. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol Lett 22 (1989) 259-261
66. Szekeres-Bartho J., Szekeres G., Debre P., et al. Reactivity of lymphocytes to a progesterone-specific monoclonal antibody. Cell Immunol 125 (1990) 273-283
67. Druckmann R., and Druckmann M.A. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 97 (2005) 389-396
68. Szekeres-Bartho J., Faust Z., and Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 34 (1995) 342-348
69. Szekeres-Bartho J., Varga P., and Petjsik B. ELISA test for detecting a progesterone-induced immunological factor in pregnancy serum. J Reprod Immunol 16 (1989) 19-29
70. Kalinka J., and Szekeres-Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Am J Reprod Immunol 53 (2005) 166-171
71. Choi B.C., Polgar K., Xiao L., et al. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15 (2000) 46-59
72. Piccinni M.P., Giudizi M.G., Biagotti R., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155 (1995) 128-133
73. Check J.H. Th1 and Th2 cytokine profiles in recurrent aborters may merely reflect progesterone status. Hum Reprod 17 (2002) 1669-1674
74. Raghupathy R., Al Mutawa E., Makhseed M., et al. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Br J Obstet Gynaecol 112 (2005) 1096-1101
75. + cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 172 (2004) 5893-5899
76. Szekeres-Bartho J., Par G., Dombay G.Y., et al. The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell Immunol 177 (1997) 194-199
77. Faust Z., Laskarin G., Rukavina D., et al. Progesterone induced blocking factor inhibits degranulation of NK cells. Am J Reprod Immunol 42 (1999) 71-75
78. Kelemen K., Bognar I., Paal M., et al. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 167 (1996) 129-134
79. Polgar B., Nagy E., Miko E., et al. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 71 (2004) 1699-1705
80. Salomon L.J., Rozenberg P., Szekeres-Bartho J., et al. Changes in progesterone-induced-blocking factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks. J Matern Fetal Neonatal Med 17 (2005) 353-356
81. Joachim R., Zenclussen A.C., Polgar B., et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 68 (2003) 931-940
82. Chaouat G., Zourbas S., Ostojic S., et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface that might challenge the classical Th-1/Th-2 dichotomy. J Reprod Immunol 53 (2002) 241-256
83. Swyer G.I.M., and Daley D. Progesterone implantation in habitual abortion. BMJ 1 (1953) 1073-1086
84. Backer Jr. M.H. Isopregnenone (Duphaston): a new progestational agent. Obstet Gynecol 19 (1962) 724-729
85. Le Vine L. Habitual abortion: a controlled clinical study of progestational therapy. West J Surg 72 (1964) 30-36
86. Goldzieher J.W. Double-blind trial of a progestin in habitual abortion. JAMA 188 (1964) 651-654
87. Gelle P., and Schaeffer P. Apropos of the use of dydrogesterone in gynecology and obstetrics; clinical experience. Bull Fed Soc Gynecol Obstet Lang Fr 17 (1965) 369-370
88. Jamain M., and Grenet C. Utilization of 6-dehydro-retroprogesterone in obstetrics: indications; results. Bull Fed Soc Gynecol Obstet Lang Fr 21 (1969) 26-31
89. Radulesco J.C. Dydrogesterone in treatment of hypohormonal pregnancy. Mars Med 107 (1970) 191-196
90. Omar M.H., Mashita M.K., Lim P.S., et al. Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol 97 (2005) 421-425
91. Arck P. Stress and embryo implantation. J Gynecol Obstet Biol Reprod 33 (2004) S40-S42
92. Reznikoff-Etievant M.F., Zittoun J., Vaylet C., et al. Low vitamin B12 level as risk factor for very early recurrent abortion. Eur J Obstet Gynecol Reprod Biol 104 (2002) 156-159
93. Li T.C. Guidelines for practitioners. Recurrent miscarriage: principles of management. Hum Reprod 13 (1998) 478-482
94. Walch K., Hefler L., and Nagele F. Oral dydrogesterone treatment during the first trimester of pregnancy: the Prevention of Miscarriage Study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial. J Matern Fetal Neonatal Med 18 (2005) 265-269
95. Resseguie L.J., Hick J.F., Bruen J.A., et al. Congenital malformations among offspring exposed in utero to progestins. Olmsted Country, Minnesota 1936-1974. Fertil Steril 43 (1985) 514-518
96. Vidal F., Gimenez C., Rubio C., et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet 15 (1998) 310-313
97. Stephenson M.D., Awartani K.A., and Robinson W.P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 17 (2002) 446-451
98. Salafia C., Maier D., Vogel C., et al. Placental and decidual histology in spontaneous abortion: detailed description and correlations with chromosome number. Obstet Gynecol 82 (1993) 295-303
99. Coomarasamy A., Thangaratinam S., Gee H., et al. Progesterone for the prevention of preterm birth: a critical evaluation of evidence. Eur J Obstet Gynecol Reprod Biol 129 (2006) 111-118
100. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 3 (2004) CD004830